Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
PTHvsXBIETF Comparison
Invesco DWA Healthcare Momentum ETF (PTH) and SPDR S&P Biotech ETF (XBI) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. PTH is more expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.35% for XBI. PTH is down -0.94% year-to-date (YTD) with -$2M in YTD flows. XBI performs better with 4.5% YTD performance, and -$163M in YTD flows. Run a side-by-side ETF comparison of PTH and XBI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PTH vs XBI performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PTH XBI | +0.87%+1.75% | -2.99%+4.75% | -0.94%+4.50% | +31.67%+48.40% | +40.70%+69.29% | -4.17%-9.32% |
| Flows | PTH XBI | --$21M | -$2M-$262M | -$2M-$163M | -$15M-$25M | -$92M-$1.83B | -$495M+$1.19B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PTH XBI | +21.14%+25.66% | +24.53%+28.03% | +24.42%+27.31% | +25.61%+32.96% |
| Max drawdown | PTH XBI | -7.58%-8.19% | -16.12%-21.44% | -29.24%-32.94% | -50.10%-57.63% |
| Max drawdown duration | PTH XBI | 86d47d | 183d141d | 271d331d | 1650d1821d |
PTH | XBI | |
Last sale 3/11/2026 at 1:30 PM | $48.86 | $126.38 |
| Previous close 03/10/2026 | $49.20 | $127.43 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PTH | XBI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PTH | XBI | |
|---|---|---|
| Last price | $48.86 | $126.38 |
| 1D performance | -0.70% | -0.82% |
| AuM | $122.13 M | $8.06 B |
| E/R | 0.72% | 0.35% |
PTH | XBI | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | SPDR |
| Benchmark | Dorsey Wright Healthcare Technical Leaders Index | S&P Biotechnology Select Industry Index |
| N° of holdings | 46 | 123 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 12, 2006 | January 31, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the PTH and XBI ETFs performed in 2026?
As of March 10, 2026, PTH is down -0.94% year-to-date (YTD), while XBI has returned 4.5%. That puts XBI better performer ahead so far this year.
Which ETF is attracting more investor money: PTH or XBI?
Year-to-date, the PTH ETF saw -$2M in flows, compared to -$163M for XBI.
Which ETF is more volatile: PTH or XBI?
Over the past year, PTH had a volatility of 24.53%, while XBI experienced 28.03%.
Which ETF is bigger: PTH or XBI?
As of March 10, 2026, PTH holds $122.13 M in assets under management (AUM), while XBI manages $8.06 B.
What sectors do the PTH and XBI ETFs invest in?
PTH leans toward sectors like Health Care. Meanwhile, XBI focuses on Health Care.
What are the top holdings of the PTH ETF and XBI ETF?
PTH top holdings include US74006W2070, GUARDANT HEALTH INC and ROIVANT SCIENCES LTD. XBI holds in its top three: MODERNA INC, MIRUM PHARMACEUTICALS INC and REVOLUTION MEDICINES INC.
Which ETF is more diversified: PTH or XBI?
PTH holds 58 securities with 50.37% of its assets in the top 15. XBI has 149 securities and a top 15 weight of 21.6%.
Small-Cap Biotech ETFs: High-Risk, High-Reward Opportunities
Are Biotechnology ETFs In the Midst of a Comeback?
Continued tightening of the U.S. labor market
Two biotech ETFs to watch for the rest of 2022 and beyond
Biotech ETFs – Investing in Health Innovation
Biotech ETFs – Investing in Health Innovation
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
